Reta vs Triz: Triple vs Dual Agonist

Comparisons — 2026-05-27

"Reta vs triz" is the comparison researchers reach for once they understand that both are multi-receptor agonists — but they are not the same generation of compound. Triz is a dual agonist; reta adds a third receptor. That one difference drives most of what follows.

Researcher special: code WELCOME at checkout unlocks 35% off Reta 10mg, Reta 20mg, Triz 10mg, and the Metabolic Stack. Every vial ships with a batch-matched COA at 99%+ HPLC purity.

The Core Difference: Two Receptors vs Three

• Triz activates GP-1 + GIP (dual agonist)
• Reta activates GP-1 + GIP + glucagon (triple agonist)

GP-1 and GIP both work primarily on the *intake* side of energy balance — appetite suppression, insulin sensitivity, gastric emptying. The glucagon receptor that reta adds works on the *output* side: it raises energy expenditure and drives hepatic fat oxidation. Reta hits both sides of the equation; triz hits one.

Head-to-Head: Weight Loss Magnitude

There is no single head-to-head trial, but the published Phase 2/3 data is clear:

Reta produced slightly greater weight loss in *less* time — consistent with the added glucagon-driven energy expenditure.

Glycemic Control

Both are strong on glucose:

• Triz: ~2.0–2.3% HbA1c reduction in the SURPASS program
• Reta: ~2.0–2.2% HbA1c reduction in Phase 2 T2D data

On glycemic endpoints the two are roughly comparable; the separation is on the weight and energy-expenditure side.

Side Effects

Both share the GP-1 class profile — nausea and GI effects during titration, appetite reduction. Reta adds glucagon-mediated effects on top:

• Mild heart rate elevation (a few bpm)
• Transient transaminase changes
• Higher overall GI burden at top doses during titration

Triz, with one fewer receptor, tends to be slightly better tolerated at comparable points in titration.

Protocol Differences

Which for Which Research Question?

Use triz when - You want a dual-agonist baseline with a larger published safety record - Tolerability during titration is a priority - Glycemic control is the primary endpoint

Use reta when - Maximum weight-loss magnitude is the endpoint - You specifically want to study the glucagon-receptor arm and energy expenditure - The protocol can accommodate a slow, multi-step titration

Stacking them? No. Both activate GP-1 and GIP — combining them is redundant and would stack GI burden without proportional benefit. Choose the one that fits the research question.

Bottom Line

Triz is the established dual agonist; reta is the next-step triple agonist that adds glucagon-driven energy expenditure for somewhat greater weight-loss magnitude, at the cost of slightly higher GI burden and a thinner long-term safety record. For related comparisons see reta vs sema and reta vs Ozempic.

Code WELCOME at checkout unlocks 35% off Reta 10mg, Reta 20mg, Triz 10mg, and the Metabolic Stack. Every vial ships with a batch-matched COA showing 99%+ HPLC purity — essential when you are comparing two compounds and need matched-quality material.

Disclaimer: All information presented in this article is for educational and informational purposes only. Platinum Biolabs does not promote or endorse the use of peptides for human consumption. All products sold by Platinum Biolabs are intended strictly for laboratory and research use only. Consult a qualified healthcare professional before making any health-related decisions.